RecruitingNCT04755855
Prospective Sinonasal Cancer Multi-institution Study
Sinonasal Cancer Study to Evaluate Oncologic Outcomes and Quality of Life
Sponsor
Mayo Clinic
Enrollment
200 participants
Start Date
Jan 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.
Eligibility
Min Age: 30 DaysMax Age: 99 Years
Inclusion Criteria3
- Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive)
- Patients with a diagnosis of sinonasal cancer
- Patients undergoing treatment at Mayo Clinic
Exclusion Criteria2
- Healthy individuals
- Unwilling to sign the informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04755855